Nkt-like (Cd3+cd56+) cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

RAFAEL SOLANA LARA2026-01-292026-01-29201910.3389/fimmu.2019.024932-s2.0-85074603793https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31011ImmunologyImmunology and AllergyNkt-like (Cd3+cd56+) cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitorsresearch article